1 active not recruiting, 1 completed. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Norovirus Acute Gastroenteritis: new trials by email Literature Review of Norovirus Acute Gastroenteritis trials Research Report on Norovirus Acute Gastroenteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis mRNA-1403, Placebo - Acute Gastroenteritis, Norovirus Acute Gastroenteritis | Phase 3 | Active not recruiting | ModernaTX, Inc. | 37864 | 2024-09-24 | 2026-05-13 |
| Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age mRNA-1403, mRNA-1405, Placebo - Norovirus Acute Gastroenteritis | Phase 1 / Phase 2 | Completed | ModernaTX, Inc. | 1407 | 2023-08-25 | 2026-10-23 |
ModernaTX, Inc. (2)
Australia (2) · United States (2) · Canada (1) · Japan (1) · Panama (1) · Puerto Rico (1) · United Kingdom (1)